Product Reviews
Categories
- Alternative Medicine
- Cancer
- Acute Promyelocytic Leukemia
- Anal Cancer
- Bladder Cancer
- Breast cancer
- Colorectal cancer
- Endometrial Cancer
- Esophageal Cancer
- Gallbladder cancer
- Gastric Cancer
- Glioblastma
- Head and Neck Cancer
- Liver Cancer
- Lung Cancer
- Lymphoma
- Melanoma
- Nasopharyngeal Cancer
- Non-Hodgkin's Disease
- Ovarian Cancer
- Pancreatic Cancer
- Prostate cancer
- Renal Cancer
- Thyroid Cancer
- Cardiovascular disease
- Central Nervous System
- Constipation
- Diabetes
- Fatty Liver
- Irritable Bowel Syndrome
- Longevity
- Motherhood
- Obesity
- Others
- Psoriasis
- Respiratory Disease
- Rheumatoid Arthritis
Archives
Tag Archives: ABSSSI
FDA approves New Antibiotic for Pneumonia and Skin Infections
The US Food and Drug Administration (FDA) approves a new injectable antibiotic, ceftaroline fosamil (Teflaro; Forest Laboratories), for treating community-acquired bacterial pneumonia (CABP) and acute bacterial skin and skin-structure infections (ABSSSI), including the methicillin-resistant Staphylococcus aureus (MRSA). Ceftaroline is a … Continue reading
Posted in Others, Respiratory Disease
Tagged ABSSSI, acute bacterial skin and skin-structure infections, Antibiotic, CABP, ceftaroline fosamil, community-acquired bacterial pneumonia, methicillin-resistant Staphylococcus aureus, MRSA, Pneumonia, Skin Infections, Teflaro
Comments Off on FDA approves New Antibiotic for Pneumonia and Skin Infections
